Thursday, 21 November 2024

Molecule AI

Drug design remains a challenging endeavor due to the complexity of the involved design space. Artificial Intelligence provides a unique shot at the problem due to its capability of enabling efficient horizon exploration. We are applying our AI capabilities in screening and de novo generation of antibodies and small molecule drugs against challenging targets such as intrinsically disordered pathogenic proteoforms involved in Parkinson’s disease.

Headquarters
Delhi, India
Company Size
51-100

News

Discovering the right partnership for novel drugs!

Delhi-based startup Molecule AI which is developing an innovative AI- based platform for drug discovery with a strong focus on data engineering and generative AI models.

AI & Biotech- Transforming each other!

Indian startup Molecule AI, based in New Delhi, is developing an innovative AI-based software platform for drug discovery, with a strong focus on data engineering and generative AI models.

KnowDis brings together stakeholders to solve healthcare problems through AI

KnowDis, a New Delhi-based deeptech startup developing cutting edge artificial intelligence (AI) algorithms and applications, virtually hosted the fourth edition of KnowDis Machine Learning Day in collaboration with Yardi School of AI, Indian Institute of Technology (IIT) Delhi

Products

Leader

Dr. Viz

Genie and Screenie